DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

Synopex Inc.

KOSDAQ:A025320 Stock Report

Market Cap: ₩354.7b

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Synopex Balance Sheet Health

Financial Health criteria checks 5/6

Synopex has a total shareholder equity of ₩178.4B and total debt of ₩51.7B, which brings its debt-to-equity ratio to 29%. Its total assets and total liabilities are ₩273.9B and ₩95.4B respectively.

Key information

28.97%

Debt to equity ratio

₩51.68b

Debt

Interest coverage ration/a
Cash₩50.64b
Equity₩178.41b
Total liabilities₩95.44b
Total assets₩273.85b

Recent financial health updates

Analysis Article • May 31

Synopex (KOSDAQ:025320) Seems To Use Debt Rather Sparingly

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Feb 16

Here's Why Synopex (KOSDAQ:025320) Can Afford Some Debt

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Recent updates

Analysis Article • Mar 29

Some May Be Optimistic About Synopex's (KOSDAQ:025320) Earnings

Shareholders appeared unconcerned with Synopex Inc.'s ( KOSDAQ:025320 ) lackluster earnings report last week. We think...
Analysis Article • Feb 15

Optimistic Investors Push Synopex Inc. (KOSDAQ:025320) Shares Up 26% But Growth Is Lacking

Synopex Inc. ( KOSDAQ:025320 ) shares have had a really impressive month, gaining 26% after a shaky period beforehand...
Analysis Article • Apr 14

Synopex Inc.'s (KOSDAQ:025320) Business Is Yet to Catch Up With Its Share Price

Synopex Inc.'s ( KOSDAQ:025320 ) price-to-earnings (or "P/E") ratio of 20.3x might make it look like a strong sell...
Analysis Article • Mar 21

Synopex (KOSDAQ:025320) Has More To Do To Multiply In Value Going Forward

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to...
Analysis Article • Mar 01

Estimating The Intrinsic Value Of Synopex Inc. (KOSDAQ:025320)

Key Insights Synopex's estimated fair value is ₩4,358 based on 2 Stage Free Cash Flow to Equity With ₩5,010 share...
Analysis Article • Nov 13

Is Now The Time To Look At Buying Synopex Inc. (KOSDAQ:025320)?

While Synopex Inc. ( KOSDAQ:025320 ) might not have the largest market cap around , it received a lot of attention from...
Analysis Article • Oct 24

Returns At Synopex (KOSDAQ:025320) Are On The Way Up

What trends should we look for it we want to identify stocks that can multiply in value over the long term? In a...
Analysis Article • Aug 26

Risks Still Elevated At These Prices As Synopex Inc. (KOSDAQ:025320) Shares Dive 25%

Synopex Inc. ( KOSDAQ:025320 ) shareholders that were waiting for something to happen have been dealt a blow with a 25...
Analysis Article • Jul 01

There's Reason For Concern Over Synopex Inc.'s (KOSDAQ:025320) Massive 26% Price Jump

Despite an already strong run, Synopex Inc. ( KOSDAQ:025320 ) shares have been powering on, with a gain of 26% in the...
Analysis Article • May 31

Synopex (KOSDAQ:025320) Seems To Use Debt Rather Sparingly

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • May 10

What Synopex Inc.'s (KOSDAQ:025320) 29% Share Price Gain Is Not Telling You

Synopex Inc. ( KOSDAQ:025320 ) shares have continued their recent momentum with a 29% gain in the last month alone. The...
Analysis Article • Apr 18

Why Synopex Inc. (KOSDAQ:025320) Could Be Worth Watching

Synopex Inc. ( KOSDAQ:025320 ), might not be a large cap stock, but it saw a decent share price growth of 18% on the...
Analysis Article • Mar 26

Synopex's (KOSDAQ:025320) Performance Is Even Better Than Its Earnings Suggest

Synopex Inc.'s ( KOSDAQ:025320 ) earnings announcement last week was disappointing for investors, despite the decent...
Analysis Article • Mar 11

Market Participants Recognise Synopex Inc.'s (KOSDAQ:025320) Revenues Pushing Shares 55% Higher

Synopex Inc. ( KOSDAQ:025320 ) shares have continued their recent momentum with a 55% gain in the last month alone...
Analysis Article • Feb 16

Here's Why Synopex (KOSDAQ:025320) Can Afford Some Debt

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Dec 25

Synopex (KOSDAQ:025320) Shareholders Have Enjoyed An Impressive 227% Share Price Gain

Synopex Inc. ( KOSDAQ:025320 ) shareholders have seen the share price descend 14% over the month. But that doesn't...

Financial Position Analysis

Short Term Liabilities: A025320's short term assets (₩120.0B) exceed its short term liabilities (₩75.6B).

Long Term Liabilities: A025320's short term assets (₩120.0B) exceed its long term liabilities (₩19.9B).


Debt to Equity History and Analysis

Debt Level: A025320's net debt to equity ratio (0.6%) is considered satisfactory.

Reducing Debt: A025320's debt to equity ratio has reduced from 72.6% to 29% over the past 5 years.

Debt Coverage: A025320's debt is well covered by operating cash flow (30.9%).

Interest Coverage: Insufficient data to determine if A025320's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/13 00:47
End of Day Share Price 2026/09/11 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Synopex Inc. is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nulliM Securities
Eui-Seob ShimNH Investment & Securities Co., Ltd.

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide